Singulair Paediatric montelukast granules provide an oral prescription option for children whose clinician has selected this medicine for ongoing asthma symptom management. Each sachet contains 4 mg of Montelukast, supplied in a granular format.
Follow the prescribed dose and schedule; suitability depends on the child's age and medical assessment. Open a sachet only when ready to administer it. Give the entire contents directly into the mouth, or mix with a spoonful of cold or room-temperature soft food, such as applesauce. Give the complete mixture within 15 minutes and discard any remainder. Do not save an opened sachet or prepared mixture for later.
Montelukast is a leukotriene receptor antagonist. Leukotrienes are substances involved in airway inflammation and tightening. By blocking their action, this medicine helps support ongoing asthma symptom control as part of a clinician-directed plan. It is not intended for sudden breathing attacks. The prescribed rescue inhaler remains necessary when directed, and other asthma medicines should only be changed by the prescriber.
Alongside the active ingredient Montelukast, the granules contain Mannitol, hydroxypropyl cellulose and magnesium stearate. These ingredients form the oral granular preparation. The enclosed leaflet provides the complete product information and should be checked for ingredient sensitivities before use.
The montelukast granules format offers practical features for prescribed administration:
Serious mood, behaviour and sleep changes have been reported with Montelukast. Stop the medicine and contact the prescriber immediately if these occur, including suicidal thoughts or behaviour.
Made in the United States, this Singulair Paediatric presentation contains 28 sachets of 4 mg oral granules. Keep the outer carton and enclosed leaflet available for checking the prescription details and administration instructions. It is available at Pharmacy Plus Kuwait.
KWD
